Developer docs
API playgroundTry for free, no card

Search company profiles

Attentive Science

Full company profile

uuid000k5yf

Namestring
Attentive Science
Legal namestring
Attentive Science, LLC
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Attentive Science is a privately held, founder-led nonclinical contract research organization (CRO) specializing in pharmacokinetics, toxicology, and safety pharmacology studies that support IND-enabling drug development programs. The company serves biotechnology, pharmaceutical, animal health, and agrochemical clients, conducting both GLP and non-GLP studies and providing SEND-compliant data conversion for FDA, TGA, and EMA submissions. Its service portfolio includes core in-vivo PK and toxicology offerings alongside specialized capabilities such as C-arm and X-ray fluoroscopic imaging for gene therapy and medical device studies, immunohistochemistry and immunofluorescence histology, and AAV biodistribution studies aligned with ICH S12 guidelines.

The company operates regional facilities in Stilwell, Kansas (USA), Melbourne (Australia), and Masdar City, Abu Dhabi (UAE), where it has established a 50,000+ square foot facility designated as a national hub for Life Sciences by the Abu Dhabi Department of Health. Attentive Science's go-to-market is a consultative, sales-led boutique CRO model that emphasizes direct client access to scientists and study directors, rapid study initiation, and competitive pricing targeted at emerging biotech companies. Revenue is generated through project-based, fee-for-service contracts priced on study complexity, test systems, and regulatory requirements, with multi-year engagement cycles.

The company's competitive position is anchored by a team of industry veterans (20+ decades combined experience) drawn from former Xenometrics, Sanofi, Pfizer, WIL Research, Quintiles, and Citoxlab backgrounds, and by regulatory credibility evidenced by AAALAC International accreditation, GLP and 21 CFR Part 11 compliance, SENDIG V3.0/V3.1 conformance, and a 2024 FDA surveillance inspection that resulted in zero study-related issues.

Short descriptiontext

Attentive Science is a privately held, boutique nonclinical CRO providing GLP and non-GLP pharmacokinetics, toxicology, and safety pharmacology services to biotech, pharmaceutical, animal health, and agrochemical clients across facilities in the USA, Australia, and Abu Dhabi.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersStilwell, United States
HQ citystring
Stilwell
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
contract research services, preclinical toxicology studies, pharmacokinetics research, safety pharmacology services, nonclinical drug development
Industry3 codes
PRIMARYHLAGAAAC
Toxicology & Safety Assessment CROs (GLP)
SECONDARYHLAGAAAB
Preclinical CROs (Discovery/Pharmacology/DMPK)
SECONDARYHLAGAAAG
Medical Writing & Regulatory Submission Support CROs
NAICS code2 codes
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Preclinical Contract Research Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Contract Research Services
TypeProfessional Services
Description

Attentive Science operates as a fee-for-service CRO providing nonclinical research services to biotech, pharmaceutical, animal health, agrochemical, and food industry clients. Services include pharmacokinetics, toxicology, and safety pharmacology studies conducted under GLP and non-GLP conditions. Revenue is generated through project-based contracts for study execution, with pricing based on study complexity, test systems, and regulatory requirements.

attentivescience.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales
Pricing details1 tier
1Custom project-based pricing based on study requirements
ModelOtherBilling cadenceMulti-year contract
Notes

No standard pricing tiers publicly disclosed. Services are quote-based, tailored to specific client study requirements including test system type, study duration, GLP/non-GLP status, and endpoint complexity.

attentivescience.com
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Attentive Science is a boutique nonclinical contract research organization (CRO) that conducts pharmacokinetics, toxicology, and safety pharmacology studies for drug development. The company executes both GLP and non-GLP studies in support of IND-enabling programs and regulatory submissions, offering specialized capabilities including C-arm/X-ray imaging for gene therapy, IHC/IF histology, AAV biodistribution studies, and SEND data conversion.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Attentive Science is a global nonclinical contract research organization (CRO) offering a unified platform of preclinical drug development services organized around three core pillars: Pharmacokinetics Studies, Toxicology Studies (including Acute, Subchronic, and IND-enabling programs), and Safety Pharmacology Studies. These core services are supported by specialized capabilities including C-arm and X-ray imaging for gene therapy and device studies, in-house histology with IHC and IF staining, AAV biodistribution studies following ICH S12 guidelines, and SEND data conversion services using Instem's submitTM. The company operates regional facilities in Stilwell, KS (USA), Melbourne, Australia, and Masdar City, Abu Dhabi (UAE), and participates in the Biosphere Labs shared laboratory partnership in Abu Dhabi. Services span both GLP-compliant and non-GLP exploratory studies across biotechnology, pharmaceutical, animal health, and agrochemical industries.

Product and service6 records
1Pharmacokinetics Studies
CategoryPreclinical CRO Services
Description

In vivo pharmacokinetic studies evaluating compound behavior within complete physiological systems, measuring systemic exposure, absorption, bioavailability, tissue distribution, metabolic pathways, and clearance rates to support candidate selection and IND-enabling programs. Targets biotech and pharmaceutical companies.

2Toxicology Studies
CategoryPreclinical CRO Services
Description

Regulatory toxicology studies evaluating relationships between drug molecule doses and adverse events, including acute, subchronic, chronic, and dose range-finding studies supporting lead optimization, candidate selection, and IND-enabling submissions. Targets biotech and pharmaceutical companies.

3Safety Pharmacology Studies
CategoryPreclinical CRO Services
Description

Safety pharmacology studies designed to detect undesirable pharmacodynamic effects of new chemical entities on physiological functions in relation to therapeutic-range and above exposure levels, leveraging a broad expert network. Targets biotech and pharmaceutical companies.

4C-arm and X-ray Imaging Services
CategorySpecialized Preclinical Capabilities
Description

Real-time fluoroscopic C-arm and X-ray imaging for preclinical gene therapy and medical device studies, enabling non-invasive visualization of catheter and injection needle navigation, gene expression monitoring, vector integrity assessment, and device placement tracking. Targets gene therapy and medical device developers.

5Histology Services (IHC and IF Staining)
CategorySpecialized Preclinical Capabilities
Description

In-house histology laboratory services including immunohistochemistry (IHC) and immunofluorescence (IF) staining, enabling molecular analysis of tissue samples with specialized markers such as CD80, CD163 EDHu antibody, and DAPI nuclear counterstaining for macrophage polarization and pathological change identification. Targets preclinical and toxicology research programs.

6SEND Data Conversion Services
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-25
Description

M42 is a health company collaborating with Attentive Science and Masdar City on Biosphere Labs, the GCC's first commercially scaled shared laboratory facility. This partnership provides researchers, startups, and biotechnology companies with access to specialized bench space, advanced equipment, and connections to Abu Dhabi's broader life sciences ecosystem through the HELM cluster. The initiative aims to position Abu Dhabi as a global destination for life sciences innovation.

2Masdar City
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-25
Description

Masdar City in Abu Dhabi hosts the Biosphere Labs facility developed in partnership with M42 and Attentive Science. Masdar City is designated by Abu Dhabi Department of Health as the national hub for Life Sciences. Attentive Science operates facilities within Masdar City as part of this strategic partnership.

gulftoday.ae
3Abu Dhabi Department of Health (DOH)
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2024-05-31
Description

Abu Dhabi Department of Health designated Masdar City as the national hub for Life Sciences and provided active support in attracting Attentive Science's expansion to Abu Dhabi. The DOH's collaborative spirit presented a unique opportunity for Attentive Science's global expansion.

attentivescience.com
Recent move2 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global CRO giant with end-to-end preclinical and clinical offerings, including the safety assessment and toxicology franchise Attentive Science competes in. Charles River acquired WIL Research and Citoxlab — both prior employers of Attentive's COO — making it the dominant incumbent in the boutique's target niche.

TypeBroad incumbent
Description

One of the largest preclinical-to-clinical CROs, with full-service safety pharmacology, toxicology, and bioanalytical labs. Competes with Attentive Science for IND-enabling programs from biotech and pharma sponsors.

TypeBroad incumbent
Description

Chinese-headquartered global CRO offering preclinical toxicology, safety pharmacology, and bioanalysis alongside broader drug-development services. Overlaps directly with Attentive Science's toxicology and PK offerings and competes for multinational biotech sponsors.

TypeDirect peer
Description

Mid-sized US preclinical CRO providing toxicology, safety pharmacology, and PK services to pharma and biotech. Closely comparable in size, services, and target customer base to Attentive Science.

TypeDirect peer
Description

Global CRO with integrated preclinical toxicology, safety pharmacology, DMPK, and bioanalytical services. Direct competitor for nonclinical CRO contracts from biotech and pharma sponsors worldwide.

TypeDirect peer
Description

US-listed CRO offering preclinical toxicology, pharmacokinetics, and bioanalytical services across US and China operations. Comparable in service mix and customer segments to Attentive Science.

7ITR Laboratories Canada
TypeDirect peer
Description

Boutique preclinical CRO specializing in general toxicology, safety pharmacology, and bioanalysis for pharma and biotech. Closely matches Attentive Science's boutique service profile.

TypeDirect peer
Description

CRO offering preclinical toxicology, safety assessment, and regulatory science services for pharmaceutical, animal health, and agrochemical clients — overlapping Attentive Science's four target verticals.

9Absorption Systems
TypeDirect peer
Description

Specialty preclinical CRO with deep expertise in ADME/PK and drug-drug interaction studies. Comparable in scale and service specialization to Attentive Science's high-throughput in-vivo PK business.

10Seventh Wave Laboratories
TypeDirect peer
Description

Boutique preclinical CRO providing in-vivo toxicology, pharmacokinetics, and safety pharmacology services to emerging biotech. Most closely mirrors Attentive Science's boutique CRO positioning and target customer profile.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Attentive Science

Preclinical Contract Research Servicesattentivescience.com

Attentive Science is a privately held, boutique nonclinical CRO providing GLP and non-GLP pharmacokinetics, toxicology, and safety pharmacology services to biotech, pharmaceutical, animal health, and agrochemical clients across facilities in the USA, Australia, and Abu Dhabi.

What Attentive Science does

Attentive Science is a privately held, founder-led nonclinical contract research organization (CRO) specializing in pharmacokinetics, toxicology, and safety pharmacology studies that support IND-enabling drug development programs. The company serves biotechnology, pharmaceutical, animal health, and agrochemical clients, conducting both GLP and non-GLP studies and providing SEND-compliant data conversion for FDA, TGA, and EMA submissions. Its service portfolio includes core in-vivo PK and toxicology offerings alongside specialized capabilities such as C-arm and X-ray fluoroscopic imaging for gene therapy and medical device studies, immunohistochemistry and immunofluorescence histology, and AAV biodistribution studies aligned with ICH S12 guidelines.

The company operates regional facilities in Stilwell, Kansas (USA), Melbourne (Australia), and Masdar City, Abu Dhabi (UAE), where it has established a 50,000+ square foot facility designated as a national hub for Life Sciences by the Abu Dhabi Department of Health. Attentive Science's go-to-market is a consultative, sales-led boutique CRO model that emphasizes direct client access to scientists and study directors, rapid study initiation, and competitive pricing targeted at emerging biotech companies. Revenue is generated through project-based, fee-for-service contracts priced on study complexity, test systems, and regulatory requirements, with multi-year engagement cycles.

The company's competitive position is anchored by a team of industry veterans (20+ decades combined experience) drawn from former Xenometrics, Sanofi, Pfizer, WIL Research, Quintiles, and Citoxlab backgrounds, and by regulatory credibility evidenced by AAALAC International accreditation, GLP and 21 CFR Part 11 compliance, SENDIG V3.0/V3.1 conformance, and a 2024 FDA surveillance inspection that resulted in zero study-related issues.

Attentive Science firmographics

Firmographics
Name
Attentive Science
Legal name
Attentive Science, LLC
Website
https://attentivescience.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
51–100 employees
Short description
Attentive Science is a privately held, boutique nonclinical CRO providing GLP and non-GLP pharmacokinetics, toxicology, and safety pharmacology services to biotech, pharmaceutical, animal health, and agrochemical clients across facilities in the USA, Australia, and Abu Dhabi.
Ownership category
akta.pro rank

Attentive Science industry classification

Industry
Product category
Preclinical Contract Research Services
NAICS
Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAAAC
Toxicology & Safety Assessment CROs (GLP)
SECONDARYHLAGAAAB
Preclinical CROs (Discovery/Pharmacology/DMPK)
SECONDARYHLAGAAAG
Medical Writing & Regulatory Submission Support CROs

Keywords

  • Contract research services
  • Preclinical toxicology studies
  • Pharmacokinetics research
  • Safety pharmacology services
  • Nonclinical drug development

Where Attentive Science is headquartered

Location

Headquarters

HQ city
Stilwell
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Attentive Science business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales

Revenue model

  1. Contract Research Services: Attentive Science operates as a fee-for-service CRO providing nonclinical research services to biotech, pharmaceutical, animal health, agrochemical, and food industry clients. Services include pharmacokinetics, toxicology, and safety pharmacology studies conducted under GLP and non-GLP conditions. Revenue is generated through project-based contracts for study execution, with pricing based on study complexity, test systems, and regulatory requirements.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom project-based pricing based on study requirements

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Attentive Science product offering

Product offering

Core offering

Attentive Science is a boutique nonclinical contract research organization (CRO) that conducts pharmacokinetics, toxicology, and safety pharmacology studies for drug development. The company executes both GLP and non-GLP studies in support of IND-enabling programs and regulatory submissions, offering specialized capabilities including C-arm/X-ray imaging for gene therapy, IHC/IF histology, AAV biodistribution studies, and SEND data conversion.

Product overview

Attentive Science is a global nonclinical contract research organization (CRO) offering a unified platform of preclinical drug development services organized around three core pillars: Pharmacokinetics Studies, Toxicology Studies (including Acute, Subchronic, and IND-enabling programs), and Safety Pharmacology Studies. These core services are supported by specialized capabilities including C-arm and X-ray imaging for gene therapy and device studies, in-house histology with IHC and IF staining, AAV biodistribution studies following ICH S12 guidelines, and SEND data conversion services using Instem's submitTM. The company operates regional facilities in Stilwell, KS (USA), Melbourne, Australia, and Masdar City, Abu Dhabi (UAE), and participates in the Biosphere Labs shared laboratory partnership in Abu Dhabi. Services span both GLP-compliant and non-GLP exploratory studies across biotechnology, pharmaceutical, animal health, and agrochemical industries.

Differentiator

Problem solved

Functional benefit

Products and services

  • Pharmacokinetics Studies In vivo pharmacokinetic studies evaluating compound behavior within complete physiological systems, measuring systemic exposure, absorption, bioavailability, tissue distribution, metabolic pathways, and clearance rates to support candidate selection and IND-enabling programs. Targets biotech and pharmaceutical companies.
  • Toxicology Studies Regulatory toxicology studies evaluating relationships between drug molecule doses and adverse events, including acute, subchronic, chronic, and dose range-finding studies supporting lead optimization, candidate selection, and IND-enabling submissions. Targets biotech and pharmaceutical companies.
  • Safety Pharmacology Studies Safety pharmacology studies designed to detect undesirable pharmacodynamic effects of new chemical entities on physiological functions in relation to therapeutic-range and above exposure levels, leveraging a broad expert network. Targets biotech and pharmaceutical companies.
  • C-arm and X-ray Imaging Services Real-time fluoroscopic C-arm and X-ray imaging for preclinical gene therapy and medical device studies, enabling non-invasive visualization of catheter and injection needle navigation, gene expression monitoring, vector integrity assessment, and device placement tracking. Targets gene therapy and medical device developers.
  • Histology Services (IHC and IF Staining) In-house histology laboratory services including immunohistochemistry (IHC) and immunofluorescence (IF) staining, enabling molecular analysis of tissue samples with specialized markers such as CD80, CD163 EDHu antibody, and DAPI nuclear counterstaining for macrophage polarization and pathological change identification. Targets preclinical and toxicology research programs.
  • SEND Data Conversion Services

Companies that use Attentive Science

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Attentive Science technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature5 records

Attentive Science partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and flagship.

  • M42coreStrategic or Co-development Partner · 25 June 2026M42 is a health company collaborating with Attentive Science and Masdar City on Biosphere Labs, the GCC's first commercially scaled shared laboratory facility. This partnership provides researchers, startups, and biotechnology companies with access to specialized bench space, advanced equipment, and connections to Abu Dhabi's broader life sciences ecosystem through the HELM cluster. The initiative aims to position Abu Dhabi as a global destination for life sciences innovation.
  • Masdar CitycoreStrategic or Co-development Partner · 25 June 2026Masdar City in Abu Dhabi hosts the Biosphere Labs facility developed in partnership with M42 and Attentive Science. Masdar City is designated by Abu Dhabi Department of Health as the national hub for Life Sciences. Attentive Science operates facilities within Masdar City as part of this strategic partnership.
  • Abu Dhabi Department of Health (DOH)flagshipStrategic or Co-development Partner · 31 May 2024Abu Dhabi Department of Health designated Masdar City as the national hub for Life Sciences and provided active support in attracting Attentive Science's expansion to Abu Dhabi. The DOH's collaborative spirit presented a unique opportunity for Attentive Science's global expansion.

Scale indicators4 records

Recent moves2 records

Expansion highlights6 records

Attentive Science competitors and assessment

Company assessment

Broad incumbents

  • Charles River Laboratories: Global CRO giant with end-to-end preclinical and clinical offerings, including the safety assessment and toxicology franchise Attentive Science competes in. Charles River acquired WIL Research and Citoxlab — both prior employers of Attentive's COO — making it the dominant incumbent in the boutique's target niche.
  • Labcorp (Covance Drug Development): One of the largest preclinical-to-clinical CROs, with full-service safety pharmacology, toxicology, and bioanalytical labs. Competes with Attentive Science for IND-enabling programs from biotech and pharma sponsors.
  • WuXi AppTec: Chinese-headquartered global CRO offering preclinical toxicology, safety pharmacology, and bioanalysis alongside broader drug-development services. Overlaps directly with Attentive Science's toxicology and PK offerings and competes for multinational biotech sponsors.

Direct peers

  • Inotiv: Mid-sized US preclinical CRO providing toxicology, safety pharmacology, and PK services to pharma and biotech. Closely comparable in size, services, and target customer base to Attentive Science.
  • Pharmaron: Global CRO with integrated preclinical toxicology, safety pharmacology, DMPK, and bioanalytical services. Direct competitor for nonclinical CRO contracts from biotech and pharma sponsors worldwide.
  • Frontage Laboratories: US-listed CRO offering preclinical toxicology, pharmacokinetics, and bioanalytical services across US and China operations. Comparable in service mix and customer segments to Attentive Science.
  • ITR Laboratories Canada: Boutique preclinical CRO specializing in general toxicology, safety pharmacology, and bioanalysis for pharma and biotech. Closely matches Attentive Science's boutique service profile.
  • Smithers: CRO offering preclinical toxicology, safety assessment, and regulatory science services for pharmaceutical, animal health, and agrochemical clients — overlapping Attentive Science's four target verticals.
  • Absorption Systems: Specialty preclinical CRO with deep expertise in ADME/PK and drug-drug interaction studies. Comparable in scale and service specialization to Attentive Science's high-throughput in-vivo PK business.
  • Seventh Wave Laboratories: Boutique preclinical CRO providing in-vivo toxicology, pharmacokinetics, and safety pharmacology services to emerging biotech. Most closely mirrors Attentive Science's boutique CRO positioning and target customer profile.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Attentive Science social profiles

Digital presence

Attentive Science compliance and trust

Trust signal

Compliance4 records

Attentive Science financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Attentive Science leadership team

Management profile

Number of profiles

Profiles7 records

Attentive Science subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Attentive Science funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Attentive Science M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Attentive Science

What does Attentive Science do?

Attentive Science is a boutique nonclinical contract research organization (CRO) that conducts pharmacokinetics, toxicology, and safety pharmacology studies for drug development. The company executes both GLP and non-GLP studies in support of IND-enabling programs and regulatory submissions, offering specialized capabilities including C-arm/X-ray imaging for gene therapy, IHC/IF histology, AAV biodistribution studies, and SEND data conversion.

Is Attentive Science a public or private company?

Attentive Science is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Attentive Science founded?

Attentive Science was founded in 2019. It employs 51 to 100 people.

Where is Attentive Science based?

Attentive Science is headquartered in Stilwell, United States, in the North America region.

How does Attentive Science make money?

One revenue line is on record: contract Research Services.

Who are Attentive Science's main competitors?

Broad incumbents on record are Charles River Laboratories, Labcorp (Covance Drug Development) and WuXi AppTec. Direct peers are Inotiv, Pharmaron, Frontage Laboratories, ITR Laboratories Canada, Smithers, Absorption Systems and Seventh Wave Laboratories.

Does Attentive Science have an API?

No public API is recorded for Attentive Science.

What industry is Attentive Science in?

Attentive Science's product category is Preclinical Contract Research Services. Its primary akta.pro industry code is HLAGAAAC, Toxicology & Safety Assessment CROs (GLP), with a secondary code of HLAGAAAB, Preclinical CROs (Discovery/Pharmacology/DMPK). Its NAICS code is 54171 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Gulf TodayMasdar City opens 'Biosphere' labs in Collaboration with M42, Attentive ScienceMasdar City announced the launch of Biosphere Labs in partnership with M42 and Attentive Science, representing the GCC's first commercially scaled shared laboratory facility, announced at the BIO International Convention 2026 in San Diego. The facility provides researchers, startups and biotechnology companies with immediate access to specialized bench space, advanced equipment and connections to Abu Dhabi's broader life sciences ecosystem through the HELM cluster. The initiative aims to reduce barriers to scientific research and position Abu Dhabi as a global destination for life sciences innovation.GulfNewsAbu Dhabi launches GCC’s first commercially scaled biotech shared labAbu Dhabi's Masdar City has launched Biosphere Labs, the GCC's first commercially scaled shared laboratory facility for biotechnology, developed in partnership with M42 and Attentive Science and announced at the BIO International Convention 2026 in San Diego. The facility provides startups, researchers, and life sciences companies with immediate access to specialist laboratory space, advanced equipment, operational support, and industry networks, eliminating substantial upfront investment barriers. The launch complements Abu Dhabi's HELM (Health, Endurance, Longevity and Medicine) cluster established at Masdar City in 2025, reinforcing the emirate's ambition to become a global life sciences hub.ZawyaMasdar City opens Biosphere Labs, the GCC’s first commercially scaled shared lab, with M42 and Attentive ScienceMasdar City launched Biosphere Labs, the GCC's first commercially scaled shared lab, in partnership with M42 and Attentive Science. The facility provides bench space, equipment, and operational support to researchers and startups, reducing costs and time. It builds on Abu Dhabi's HELM cluster and aims to attract global talent and accelerate discoveries.AETOSWireInnovive Expands Global Reach Through Strategic Partnership with Attentive Science to Accelerate Scientific Research Acr...Innovive signed a distribution and co-marketing agreement with Attentive Science for the GCC and MENA regions. Attentive Science will distribute Innovive's wash-free recyclable caging systems and collaborate on its Inno+ vivarium services. The partnership aims to expand Innovive's presence in the region's growing biotech and pharmaceutical sector.Gulf TodayMasdar City chosen as Middle East HQ for Attentive ScienceAttentive Science, a global non-clinical research services provider, selected Masdar City as its Middle East hub. The company tests drugs in early development using living test subjects. The UAE is its third global location, following expansions into Australia and the US.